| OCULIS HLDG AG SF -,01 |
| Schweiz |
| Gesundheit |
| CH1242303498 / A3D8QG |
| CR5 (Frankfurt) / OCS (NASDAQ) |
| FRA:CR5, ETR:CR5, CR5:GR, NASDAQ:OCS |
| - |
| https://oculis.com/ |
|
Oculis Holding AG operates as a key player within ..
>Volltext.. |
| 966.82 Mio. EUR |
| 813.93 Mio. EUR |
| - |
| -79.05 Mio. EUR |
| -103.47 Mio. EUR |
| -2.15 EUR |
| 2.64 Mio. EUR |
| 49.75 Mio. EUR |
| -60.83 Mio. EUR |
| 4.3 |
| - |
| -53.98% |
| - |
| - |
| - |
| - |
| OCULIS |
| 18.12.25 |
|